 Results: At 6 months 5 of 7 patients 71.4 of group 1 and 8 of 8 patients 100 of group 2 had lost fewer than 15 letters P.001. Three patients 37.5 of group 2 had an improvement of 3 lines or more. Lesion type, patient age, and lesion size had no influence on the outcome, but baseline VA had a statistically significant effect P .006. The median number of treatments in both groups was one. The 28 of PDT-triamcinolone group and 25 of triple therapy group had an increase in intraocular pressure IOP that required therapy. Progression or development of cataract was observed in 14.2 in PDT- IVTA group and 12.5 in Triple therapy group. There were no cases of endophthalmitis. No cardiac or cerebrovascular accidents where presented. 